13F Insight
DOSSIER · 13F-HR · Q1 2026

StepStone Group LP

StepStone's hedge fund based in London, UK — $207M in tracked AUM across 18 positions as of Q1 2026.

S
StepStone·London, UK·Hedge Fund
CIK 0001502287 · last filed Mar 31, 2026
Total AUM
$207M
▲ 6.2%
vs prior
Holdings
18
—
positions
Whale Score
71
71
strong
Activity
—
no data
changes this Q
Top sector
Tech
12% weight
concentration
AI Analysis · Q1 2026 · Q1 2026
Comprehensive Analysis of StepStone Group LP (SEC 13F) – Q3 2025
Portfolio Overview

The filing for StepStone Group LP (CIK: 0001502287) reveals a highly specialized and concentrated portfolio that underwent a dramatic transformation during the quarter ending September 30, 2025. The total portfolio value surged by 238.5%, growing from $50.43M to $170.70M. This massive increase in assets under management (AUM) was driven almost entirely by a single new allocation.

The portfolio ...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
KRMN
KARMAN HLDGS INC
$70M877K33.8%
02
STUB
STUBHUB HLDGS INC
$47M7.6M22.7%
03
XNDU
XANADU QUANTUM TECHNOLO LTD
$26M3.4M12.6%
04
OKUR
ONKURE THERAPEUTICS INC
$11M2.7M5.3%
05
PATH
UIPATH, INC.
$10M903K4.8%
06
KDK
KODIAK AI INC.
$10M1.4M4.7%
07
TRDA
ENTRADA THERAPEUTICS INC.
$10M761K4.6%
08
NAVN
NAVAN INC
$6M484K3.1%
09
PHAT
PHATHOM PHARMACEUTICALS INC.
$5M422K2.3%
10
EIKN
EIKON THERAPEUTICS INC
$4M395K2.0%

Filing history

Filing history loading…